Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
05/2007
05/24/2007CA2630680A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer~s disease, neurodegeneration and dementia.
05/24/2007CA2629781A1 Aminopyrimidines useful as kinase inhibitors
05/24/2007CA2629468A1 Pyrazolyl urea derivatives useful in the treatment of cancer
05/24/2007CA2629317A1 Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
05/24/2007CA2628650A1 Quinazolines useful as modulators of voltage gated ion channels
05/23/2007EP1787982A2 11Beta-Hydroxysteroid dehydrogenase type 1 active compounds
05/23/2007EP1786806A1 Dpp-iv inhibitors
05/23/2007EP1786803A1 Pyrimidinylpyrazoles as tgf-beta inhibitors
05/23/2007EP1786802A1 Pyrimidinylimidazoles as tgf-beta inhibitors
05/23/2007EP1786801A1 Cytokine inhibitors
05/23/2007EP1786800A2 Substituted biaryl piperazinyl-pyridine analogues
05/23/2007EP1786786A1 Adamantyl derivates as p2x7 receptor antagonists
05/23/2007EP1786779A1 4-arylazo-3,5-diamino-pyrazole compounds and use thereof
05/23/2007EP1786777A1 Aminoheteroaryl compounds as protein tyrosine kinase inhibitors
05/23/2007EP1786773A1 Isoindolin-1-one derivatives
05/23/2007EP1786770A1 N-(1-(2,3-dihydro-1h-inden-5yl) -2-oxo-3-pyrrolidinyl) -sulfonamide derivatives for use as factor xa inhibitors
05/23/2007EP1786769A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
05/23/2007EP1786427A2 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers
05/23/2007EP1585743B1 2-(1h-indazol-6-ylamino)- benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases
05/23/2007EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
05/23/2007EP1238974B1 Heterocycle derivatives and drugs
05/23/2007EP1181014B1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD
05/23/2007CN1968949A Proline derivatives and their use as dipeptidyl peptidase IV inhibitors
05/23/2007CN1968948A Processes for preparing gonadotropin releasing hormone receptor antagonists
05/23/2007CN1968947A Heterocyclic condensed compounds useful as antidiuretic agents
05/23/2007CN1968945A Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase
05/23/2007CN1968937A Pyrimidin-4-one derivatives and their use as P38 kinase modulators
05/23/2007CN1968923A Method for producing acetamidopyrrolidine derivative and intermediate compound thereof
05/22/2007US7220856 Substituted quinoline CCR5 receptor antagonists
05/22/2007US7220781 Meta-benzamidine derivatives as serine protease inhibitors
05/22/2007US7220777 Lactam derivatives as antagonists for human 11cby receptors
05/22/2007US7220774 Protein kinase c inhibitors; antiinflammatory agents; immunosuppresants; antidiabetic agents; immunomodulators
05/22/2007US7220773 Heterocylic amines used as antidiabetic or hyperglycemic agents
05/22/2007US7220771 Jun n-terminal kinase inhibitors
05/22/2007US7220770 preferably selectively inhibit cyclooxygenase-2 over cyclooxygenase-1; arthritis treament
05/22/2007US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis
05/22/2007US7220763 Indole-type derivatives as inhibitors of p38 kinase
05/22/2007US7220750 Quinoline or quinazoline derivatives; antitumor agent, treating respiratory tract and gastrointestinal disorders
05/22/2007US7220746 For therapy of bronchitis, allergic bronchitis, bronchial asthma, emphysema, COPD and allergic rhinitis
05/22/2007US7220745 Viricides; therapy for hepatitis virus infections
05/22/2007US7220739 Therapeutic application of pro-apoptotic benzodiazepines
05/22/2007US7220736 Pyrimidine compounds
05/22/2007CA2241466C Pharmaceutical composition containing angiotensin ii antagonist
05/22/2007CA2241263C N-arylsulfilimine compounds and their use as catalysts in the preparation of n-arylarylsulfonamide compounds
05/18/2007WO2007056469A2 Certain chemical entities, compositions, and methods
05/18/2007WO2007056330A1 Benzimidazole derivatives as gyrase inhibitors
05/18/2007WO2007056228A2 5-lipoxygenase-activating protein (flap) inhibitors
05/18/2007WO2007056220A2 5-lipoxygenase-activating protein (flap) inhibitors
05/18/2007WO2007056155A1 Heterocyclic compounds as tyrosine kinase modulators
05/18/2007WO2007056075A2 Six membered heteroaromatic inhibitors targeting resistant kinase mutations
05/18/2007WO2007056023A2 Thiazole inhibitors targeting resistant kinase mutations
05/18/2007WO2007056021A2 5-lipoxygenase-activating protein (flap) inhibitors
05/18/2007WO2007054979A1 Process for the large scale production of rizatriptan benzoate
05/18/2007WO2007054748A1 Indole derivatives as antitumoural compounds
05/18/2007WO2007054739A1 Tetrahydroindole derivatives for treatment of alzheimer's disease
05/18/2007WO2007054480A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor
05/18/2007WO2007054453A2 Carbocyclic fused cyclic amines as inhibitors of the coagulation factor xa
05/18/2007WO2007035841A9 Analogs of dehydrophenylahistins and their therapeutic use
05/18/2007WO2007029086A3 Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-iv inhibitors
05/18/2007WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors
05/18/2007WO2007028083A3 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
05/18/2007WO2007023073A3 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof
05/18/2007WO2006081807A3 Method for the production of losartan
05/18/2007CA2669736A1 Heterocyclic compounds as tyrosine kinase modulators
05/18/2007CA2628934A1 Tetrahydroindole derivatives for treatment of alzheimer's disease
05/18/2007CA2628624A1 Indole derivatives as antitumoural compounds
05/18/2007CA2627808A1 Aminopyrimidines useful as kinase inhibitors
05/18/2007CA2627426A1 Carbocyclic fused cyclic amines as inhibitors of the coagulation factor xa
05/18/2007CA2627263A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor
05/18/2007CA2626685A1 Benzimidazole derivatives as gyrase inhibitors
05/17/2007US20070112195 metalating a nicotines with lithium teramethylpipridine in presence of trialkyl or aryltin halide to form an intermediate such as 1-methylpyrrolidin-2-yl)-2-tricyclohexylstannanyl)pyridine, halogenating intermediate with I2, Br2 or N-bromosuccinimide; nicotinic acetylcholine receptor modulator
05/17/2007US20070112055 Crystalline forms of almotriptan and processes for their preparation
05/17/2007US20070112037 Pyrazole Derivatives
05/17/2007US20070112036 Opioid receptor antagonists
05/17/2007US20070112034 2-(benzimidazol-1-yl)-acetamide bisaryl derivatives
05/17/2007US20070112033 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
05/17/2007US20070112012 Carbocyclic fused cyclic amines
05/17/2007US20070112009 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
05/17/2007US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma
05/17/2007US20070111998 Novel heterocyclic compounds as pSTAT3/IL-6 inhibitors
05/17/2007US20070111992 Cathepsin K and cathepsin S dependent disorders such as osteoporosis, atherosclerosis, inflammation and immune disorders such as rheumatoid arthritis and chronic pain; e.g. 4-(piperazin-1-yl)-6-(3-trifluoromethylphenyl)-pyrimidine-2-carbonitrile
05/17/2007US20070111982 Calcitonin Gene-Related Peptide, CGRP; treatment of migraine and cluster headache; 2,5-dioxo-3',4'-dihydro-spiro(imidazolidine-4,2'(1'H)-naphthalene)-6'-carboxamides
05/16/2007EP1785418A1 Pyrazole derivative
05/16/2007EP1784401A1 Urea derivatives as calcium channel blockers
05/16/2007EP1784400A1 Histamine h3 receptor agents, preparation and therapeutic uses
05/16/2007EP1784399A2 Pyrimidine derivatives
05/16/2007EP1784398A1 Purification of olmesartan medoxomil
05/16/2007EP1784397A1 5-(1,1'-biphenyl)-4-yl-5-(4-(4-aminoacylphenyl)-piperazin)-1-yl-pyrimidine-2,4,6-trione derivatives, as inhibitors of zinc metallondopeptidases, their preparation and use
05/16/2007EP1784393A1 Quinazolines useful as modulators of ion channels
05/16/2007EP1784392A2 Pyrimidine derivatives
05/16/2007EP1784187A2 Androgen receptor modulators
05/16/2007EP1303307B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents
05/16/2007CN1964970A Iap的抑制剂 Iap inhibitors
05/16/2007CN1964946A 2-propylene-1-ones as hsp70 inducer
05/16/2007CN1964944A Indole derivatives as antiviral agents
05/16/2007CN1962656A Indomethacin 5-fluorouracil methyl ester pharmaceutical compound and its formulation and preparation method
05/16/2007CN1962641A Metalloproteinase inhibitors
05/16/2007CN1315838C 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
05/16/2007CN1315823C New method for synthesizing Ramosetron Hydrochloride
05/16/2007CN1315811C Pyrimidine derivatives and preparing method thereof